Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruozhen Hu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Nature Communications|February 21, 2014
Genome-wide transcriptome profiling of homologous recombination DNA repairGuang Peng, Curtis Chun-Jen Lin, Wei Mo, et al.
Oncotarget|October 13, 2015
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitisMarah C Runtsch, Ruozhen Hu, Margaret Alexander, et al.
The Journal of Biological Chemistry|September 16, 2017
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockadeThomas B Huffaker, Soh-Hyun Lee, William W Tang, et al.
Plos Genetics|February 16, 2019
Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic diseaseMarah C Runtsch, Morgan C Nelson, Soh-Hyun Lee, et al.
Journal of Medicinal Chemistry|November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) InhibitorsJeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Blood|April 23, 2017
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseJared A Wallace, Dominique A Kagele, Anna M Eiring, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Nature|August 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nature Communications|February 21, 2014
Genome-wide transcriptome profiling of homologous recombination DNA repairGuang Peng, Curtis Chun-Jen Lin, Wei Mo, et al.
Oncotarget|October 13, 2015
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitisMarah C Runtsch, Ruozhen Hu, Margaret Alexander, et al.
The Journal of Biological Chemistry|September 16, 2017
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockadeThomas B Huffaker, Soh-Hyun Lee, William W Tang, et al.
Plos Genetics|February 16, 2019
Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic diseaseMarah C Runtsch, Morgan C Nelson, Soh-Hyun Lee, et al.
Journal of Medicinal Chemistry|November 21, 2023
Imidazolone as an Amide Bioisostere in the Development of β-1,3-<i>N</i>-Acetylglucosaminyltransferase 2 (B3GNT2) InhibitorsJeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, et al.
Blood|April 23, 2017
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseJared A Wallace, Dominique A Kagele, Anna M Eiring, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Nature|August 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Nature|February 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cellsXiangnan Guan, Ruozhen Hu, Yoonha Choi, et al.
Pageof 4